112 related articles for article (PubMed ID: 19273458)
1. Effect of cell differentiation for neuroblastoma by vitamin k analogs.
Nakayama T; Asami S; Ono S; Miura M; Hayasaka M; Yoshida Y; Toriyama M; Motohashi S; Suzuki T
Jpn J Clin Oncol; 2009 Apr; 39(4):251-9. PubMed ID: 19273458
[TBL] [Abstract][Full Text] [Related]
2. A novel cyclophane compound, CPPy, facilitates NGF-induced TrkA signal transduction and induces cell differentiation in neuroblastoma.
Yamaguchi Y; Tabata K; Asami S; Miyake M; Suzuki T
Biol Pharm Bull; 2007 Apr; 30(4):638-43. PubMed ID: 17409494
[TBL] [Abstract][Full Text] [Related]
3. The RET and TRKA pathways collaborate to regulate neuroblastoma differentiation.
Peterson S; Bogenmann E
Oncogene; 2004 Jan; 23(1):213-25. PubMed ID: 14712226
[TBL] [Abstract][Full Text] [Related]
4. Local anesthetics suppress nerve growth factor-mediated neurite outgrowth by inhibition of tyrosine kinase activity of TrkA.
Takatori M; Kuroda Y; Hirose M
Anesth Analg; 2006 Feb; 102(2):462-7. PubMed ID: 16428543
[TBL] [Abstract][Full Text] [Related]
5. Mevastatin-induced neurite outgrowth of neuroblastoma cells via activation of EGFR.
Evangelopoulos ME; Weis J; Krüttgen A
J Neurosci Res; 2009 Jul; 87(9):2138-44. PubMed ID: 19224573
[TBL] [Abstract][Full Text] [Related]
6. Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells.
Eggert A; Ikegaki N; Liu X; Chou TT; Lee VM; Trojanowski JQ; Brodeur GM
Oncogene; 2000 Apr; 19(16):2043-51. PubMed ID: 10803465
[TBL] [Abstract][Full Text] [Related]
7. A food-derived synergist of NGF signaling: identification of protein tyrosine phosphatase 1B as a key regulator of NGF receptor-initiated signal transduction.
Shibata T; Nakahara H; Kita N; Matsubara Y; Han C; Morimitsu Y; Iwamoto N; Kumagai Y; Nishida M; Kurose H; Aoki N; Ojika M; Uchida K
J Neurochem; 2008 Dec; 107(5):1248-60. PubMed ID: 18796006
[TBL] [Abstract][Full Text] [Related]
8. All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit.
Cernaianu G; Brandmaier P; Scholz G; Ackermann OP; Alt R; Rothe K; Cross M; Witzigmann H; Tröbs RB
J Pediatr Surg; 2008 Jul; 43(7):1284-94. PubMed ID: 18639684
[TBL] [Abstract][Full Text] [Related]
9. Differences in gene expression profile among SH-SY5Y neuroblastoma subclones with different neurite outgrowth responses to nerve growth factor.
Oe T; Sasayama T; Nagashima T; Muramoto M; Yamazaki T; Morikawa N; Okitsu O; Nishimura S; Aoki T; Katayama Y; Kita Y
J Neurochem; 2005 Sep; 94(5):1264-76. PubMed ID: 15992370
[TBL] [Abstract][Full Text] [Related]
10. Artificially accumulated beta-catenin inhibits proliferation and induces neurite extension of neuroblastoma cell line NB-1 via up-regulation of trkA.
Sangkhathat S; Nara K; Kusafuka T; Yoneda A; Fukuzawa M
Oncol Rep; 2006 Dec; 16(6):1197-203. PubMed ID: 17089037
[TBL] [Abstract][Full Text] [Related]
11. Expression of KIT and PDGFR is associated with a good prognosis in neuroblastoma.
Shimada A; Hirato J; Kuroiwa M; Kikuchi A; Hanada R; Wakai K; Hayashi Y
Pediatr Blood Cancer; 2008 Feb; 50(2):213-7. PubMed ID: 17941064
[TBL] [Abstract][Full Text] [Related]
12. Neuronal differentiation in human neuroblastoma cells by nerve growth factor following TrkA up-regulation by interferon-gamma.
Shikata A; Shikata T; Sotozono Y; Hosoi H; Matsumura T; Sugimoto T; Sawada T
Med Pediatr Oncol; 2000 Jun; 34(6):394-401. PubMed ID: 10842245
[TBL] [Abstract][Full Text] [Related]
13. Functional cooperation between TrkA and p75(NTR) accelerates neuronal differentiation by increased transcription of GAP-43 and p21(CIP/WAF) genes via ERK1/2 and AP-1 activities.
Diolaiti D; Bernardoni R; Trazzi S; Papa A; Porro A; Bono F; Herbert JM; Perini G; Della Valle G
Exp Cell Res; 2007 Aug; 313(14):2980-92. PubMed ID: 17619016
[TBL] [Abstract][Full Text] [Related]
14. Protein tyrosine phosphatase receptor type Z dephosphorylates TrkA receptors and attenuates NGF-dependent neurite outgrowth of PC12 cells.
Shintani T; Noda M
J Biochem; 2008 Aug; 144(2):259-66. PubMed ID: 18477627
[TBL] [Abstract][Full Text] [Related]
15. The VIP-receptor system in neuroblastoma cells.
Muller JM; Philippe M; Chevrier L; Héraud C; Alleaume C; Chadéneau C
Regul Pept; 2006 Nov; 137(1-2):34-41. PubMed ID: 16989911
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic cell death in TrkA-overexpressing cells: kinetic regulation of ERK phosphorylation and caspase-7 activation.
Jung EJ; Kim DR
Mol Cells; 2008 Jul; 26(1):12-7. PubMed ID: 18511888
[TBL] [Abstract][Full Text] [Related]
17. The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells.
Farina AR; Tacconelli A; Cappabianca L; Cea G; Chioda A; Romanelli A; Pensato S; Pedone C; Gulino A; Mackay AR
Oncogene; 2009 Nov; 28(46):4075-94. PubMed ID: 19734938
[TBL] [Abstract][Full Text] [Related]
18. TrkA signal transduction pathways in neuroblastoma.
Eggert A; Ikegaki N; Liu XG; Chou TT; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):108-10. PubMed ID: 11464858
[TBL] [Abstract][Full Text] [Related]
19. Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation.
Montano X
Oncogene; 2009 Oct; 28(43):3787-800. PubMed ID: 19749791
[TBL] [Abstract][Full Text] [Related]
20. Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiation.
Emdal KB; Pedersen AK; Bekker-Jensen DB; Tsafou KP; Horn H; Lindner S; Schulte JH; Eggert A; Jensen LJ; Francavilla C; Olsen JV
Sci Signal; 2015 Apr; 8(374):ra40. PubMed ID: 25921289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
